Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$284,036
+$34,629 QoQ
Shares Held
2,038
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CALTON & ASSOCIATES, INC. holds $9,328,876 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,827 | $3,390,788 | |
| 2 | JNJ |
Johnson & Johnson
|
6,320 | $1,605,090 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,693 | $1,245,550 | |
| 4 | ABBV |
AbbVie Inc.
|
4,822 | $1,213,408 | |
| 5 | PFE |
Pfizer Inc
|
26,875 | $647,150 | |
| 6 | AMGN |
Amgen Inc
|
1,111 | $402,315 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,244 | $302,159 | |
| 8 | GSK |
GSK plc
|
5,418 | $284,011 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $284,036 | 2,038 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $249,407 | 2,032 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $218,448 | 1,968 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $216,418 | 1,952 | Shares | Sole | 2025-08-12 | |
| 2021-09-30 | $276,466 | 3,958 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $286,595 | 4,162 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $228,079 | 3,529 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $210,959 | 3,621 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $354,938 | 5,617 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $353,539 | 4,595 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $541,337 | 7,241 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||